These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 31831431)
1. Designing a New Multi-Epitope Pertussis Vaccine with Highly Population Coverage Based on a Novel Sequence and Structural Filtration Algorithm. Ghasemnejad A; Bazmara S; Shadmani M; Bagheri KP IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(5):1885-1892. PubMed ID: 31831431 [TBL] [Abstract][Full Text] [Related]
2. In silico rational design of a novel tetra-epitope tetanus vaccine with complete population coverage using developed immunoinformatics and surface epitope mapping approaches. Bazmara S; Shadmani M; Ghasemnejad A; Aghazadeh H; Pooshang Bagheri K Med Hypotheses; 2019 Sep; 130():109267. PubMed ID: 31383332 [TBL] [Abstract][Full Text] [Related]
3. Designing a Novel di-epitope Diphtheria Vaccine: A Rational Structural Immunoinformatics Approach. Shadmani M; Ghasemnejad A; Bazmara S; Bagheri KP Curr Comput Aided Drug Des; 2024 Apr; ():. PubMed ID: 38676475 [TBL] [Abstract][Full Text] [Related]
4. Characterization of Individual Human Antibodies That Bind Pertussis Toxin Stimulated by Acellular Immunization. Acquaye-Seedah E; Reczek EE; Russell HH; DiVenere AM; Sandman SO; Collins JH; Stein CA; Whitehead TA; Maynard JA Infect Immun; 2018 Jun; 86(6):. PubMed ID: 29581192 [TBL] [Abstract][Full Text] [Related]
5. Genetically detoxified pertussis toxin (PT-9K/129G): implications for immunization and vaccines. Seubert A; D'Oro U; Scarselli M; Pizza M Expert Rev Vaccines; 2014 Oct; 13(10):1191-204. PubMed ID: 25183193 [TBL] [Abstract][Full Text] [Related]
6. Characterization of a key neutralizing epitope on pertussis toxin recognized by monoclonal antibody 1B7. Sutherland JN; Maynard JA Biochemistry; 2009 Dec; 48(50):11982-93. PubMed ID: 19899804 [TBL] [Abstract][Full Text] [Related]
7. Antibodies recognizing protective pertussis toxin epitopes are preferentially elicited by natural infection versus acellular immunization. Sutherland JN; Chang C; Yoder SM; Rock MT; Maynard JA Clin Vaccine Immunol; 2011 Jun; 18(6):954-62. PubMed ID: 21508166 [TBL] [Abstract][Full Text] [Related]
8. Development a multi-epitope driven subunit vaccine for immune response reinforcement against Serogroup B of Neisseria meningitidis using comprehensive immunoinformatics approaches. Rostamtabar M; Rahmani A; Baee M; Karkhah A; Prajapati VK; Ebrahimpour S; Nouri HR Infect Genet Evol; 2019 Nov; 75():103992. PubMed ID: 31394292 [TBL] [Abstract][Full Text] [Related]
9. Antibody persistence after vaccination of adolescents with monovalent and combined acellular pertussis vaccines containing genetically inactivated pertussis toxin: a phase 2/3 randomised, controlled, non-inferiority trial. Pitisuttithum P; Chokephaibulkit K; Sirivichayakul C; Sricharoenchai S; Dhitavat J; Pitisuthitham A; Phongsamart W; Boonnak K; Lapphra K; Sabmee Y; Wittawatmongkol O; Chauhan M; Wijagkanalan W; Hommalai G; Fortuna L; Chinwangso P; Poredi IK; van den Biggelaar AHJ; Pham HT; Viviani S Lancet Infect Dis; 2018 Nov; 18(11):1260-1268. PubMed ID: 30266329 [TBL] [Abstract][Full Text] [Related]
10. Designing an efficient multi-epitope oral vaccine against Helicobacter pylori using immunoinformatics and structural vaccinology approaches. Nezafat N; Eslami M; Negahdaripour M; Rahbar MR; Ghasemi Y Mol Biosyst; 2017 Mar; 13(4):699-713. PubMed ID: 28194462 [TBL] [Abstract][Full Text] [Related]
11. Unbinding forces of single pertussis toxin-antibody complexes measured by atomic force spectroscopy correlate with their dissociation rates determined by surface plasmon resonance. Moreno N; Chevalier M; Ronzon F; Manin C; Dupuy M; Krell T; Rieu JP J Mol Recognit; 2011; 24(6):1105-14. PubMed ID: 22038817 [TBL] [Abstract][Full Text] [Related]
12. A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster vaccines in adults. Leroux-Roels G; Lattanzi M; Solis CD; Contorni M; Costantini M; Moraschini L; Bardelli M; Bertholet S; Borgogni E; Buricchi F; Cantisani R; Faenzi E; Finco O; Leuzzi R; Pizza M; Rosa D; Schiavetti F; Seubert A; Spensieri F; Volpini G; Zedda L; Giudice GD; Galgani I Hum Vaccin Immunother; 2018 Jan; 14(1):45-58. PubMed ID: 29172945 [TBL] [Abstract][Full Text] [Related]
13. Investigating pertussis toxin and its impact on vaccination. Coutte L; Locht C Future Microbiol; 2015; 10(2):241-54. PubMed ID: 25689536 [TBL] [Abstract][Full Text] [Related]
14. Transgenic tomatoes express an antigenic polypeptide containing epitopes of the diphtheria, pertussis and tetanus exotoxins, encoded by a synthetic gene. Soria-Guerra RE; Rosales-Mendoza S; Márquez-Mercado C; López-Revilla R; Castillo-Collazo R; Alpuche-Solís AG Plant Cell Rep; 2007 Jul; 26(7):961-8. PubMed ID: 17619922 [TBL] [Abstract][Full Text] [Related]
15. Immuno-informatics Analysis to Identify Novel Vaccine Candidates and Design of a Multi-Epitope Based Vaccine Candidate Against Kar PP; Srivastava A Front Immunol; 2018; 9():2213. PubMed ID: 30374343 [TBL] [Abstract][Full Text] [Related]
17. Identification of linear B epitopes of pertactin of Bordetella pertussis induced by immunization with whole and acellular vaccine. da Silva FR; Napoleão-Pego P; De-Simone SG Vaccine; 2014 Oct; 32(47):6251-8. PubMed ID: 25252193 [TBL] [Abstract][Full Text] [Related]
18. Engineering bacterial toxin for the development of new vaccine against pertussis. Bartoloni A; Pizza M; Gross R; Perugini M; Arico B; Domenighini M; Rappuoli R Tokai J Exp Clin Med; 1988; 13 Suppl():217-22. PubMed ID: 2483870 [TBL] [Abstract][Full Text] [Related]
19. Designing an efficient multi-epitope peptide vaccine against Vibrio cholerae via combined immunoinformatics and protein interaction based approaches. Nezafat N; Karimi Z; Eslami M; Mohkam M; Zandian S; Ghasemi Y Comput Biol Chem; 2016 Jun; 62():82-95. PubMed ID: 27107181 [TBL] [Abstract][Full Text] [Related]